Mellow Fellow pushes consumer education and transparency in hemp cannabinoid market

Mellow Fellow said June 18, 2026, that hemp-derived cannabinoid buyers need clearer labels, accessible testing information and stronger industry standards as regulators and businesses debate the market’s future. The Florida brand says it will keep investing in consumer education as the sector matures. Why it matters: - Consumers in the hemp-derived cannabinoid market often face confusing product labels and uneven information. - Mellow Fellow says clearer labeling, testing access and education can help buyers make more informed decisions. - Stronger standards could also improve trust across consumers, retailers, manufacturers and regulators. What happened: - Mellow Fellow issued a statement on June 18, 2026, in Fort Lauderdale, Florida, urging continued focus on consumer education, product transparency and clear industry standards. - The company framed the message as policymakers, regulators and businesses keep debating hemp-derived cannabinoid products across the United States. - Gerard Coombs Jr., co-founder of Mellow Fellow, said consumers should not need specialized legal or regulatory knowledge to understand what they are buying. The details: - Mellow Fellow said consumers benefit most when they have accurate product information, transparent labeling and third-party testing information. - Coombs said the hemp marketplace has evolved rapidly over the last several years, while many consumers are still trying to understand differences between products, cannabinoids and labeling. - Coombs said responsible operators should stay focused on consistency, transparency and consumer trust, regardless of how state and federal rules evolve. - Coombs said consumers, retailers, manufacturers and regulators all benefit when expectations are clear. - Mellow Fellow supports clear product descriptions, accessible testing information and responsible marketing practices. - The company said it will continue investing in consumer education and product information resources as the hemp-derived cannabinoid marketplace matures. - Mellow Fellow describes itself as a Florida-based cannabinoid brand focused on consumer education, product transparency and accessible third-party testing information. - Mellow Fellow says it develops hemp-derived cannabinoid products and educational resources designed to help consumers make informed purchasing decisions. - Arvida Labs, also based in Florida, is a product development and manufacturing company serving brands in the cannabinoid industry. - Arvida Labs says it supports formulation, manufacturing and operational infrastructure for a portfolio of consumer products and brands. - Mellow Fellow posted social links to its LinkedIn page and its Instagram account . Between the lines: - The statement positions Mellow Fellow on the side of tighter consumer-facing standards at a time when the hemp market remains under regulatory pressure. - The emphasis on testing and labeling suggests brands may see transparency as a competitive advantage, not just a compliance issue. - The message also signals that the company wants rules to be understood by ordinary consumers, not only by industry insiders. What’s next: - Mellow Fellow said it will keep building consumer education and product information resources. - The company expects the discussion over hemp-derived cannabinoid standards to continue as the marketplace matures. - Future state and federal policy changes could shape how brands label, market and document cannabinoid products.